Company
Scioto Biosciences
Optimizing microbiome delivery for the benefit of children and adults with autism and GI disorders.
- Status
- Operatingas of 2026-09-23
- Founded
- 2017
- Legal name
- Scioto Biosciences, Inc.
- sciotobiosciences.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 23 September 2026
About
Scioto Biosciences leverages discovery to improve lives. Good bacteria in our bodies have the potential to promote health and treat disease. Science suggests now that many disorders previously not considered GI disorders may indeed be connected to the gut and the ecology of the microbiome. By understanding and enhancing the healthy functions of good bacteria, we can prevent and treat many diseases.
Funding snapshot
- Total raised
- $2.3MSum of rounds, as of 2026-09-20Source (opens in a new tab)
- Latest round
- Series B
Funding rounds
- Round, 2018
- $1.8M2018-04-23, SEC form D sold, 13 investors
- Series B
- Recorded
- Grant
- $2.3MCompany stated
Products
- Other
- SB-121
Loading relationship preview